- Home
- QGEN vs WAL Comparison
QGEN vs WAL Comparison
Compare QGEN & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QGEN | WAL |
|---|---|---|
| Founded | 1986 | 1994 |
| Country | Netherlands | United States |
| Employees | N/A | 3524 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 9.6B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | QGEN | WAL |
|---|---|---|
| Price | $41.95 | $69.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 16 |
| Target Price | $51.30 | ★ $98.40 |
| AVG Volume (30 Days) | ★ 1.7M | 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.61% | 2.32% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.23 | $20.16 |
| Revenue Next Year | $5.70 | $8.63 |
| P/E Ratio | $24.01 | ★ $10.88 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.13 | $57.05 |
| 52 Week High | $57.82 | $97.23 |
Technical Indicators
Market Signals| Indicator | QGEN | WAL |
|---|---|---|
| Relative Strength Index (RSI) | 21.57 | 26.25 |
| Support Level | $41.11 | N/A |
| Resistance Level | $49.11 | $89.70 |
| Average True Range (ATR) | 0.89 | 3.85 |
| MACD | -0.72 | -1.92 |
| Stochastic Oscillator | 0.13 | 7.19 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.